OutSee
OutSee’s genomics analysis technology, Nomaly, leverages a powerful AI engine and predictive algorithm to uncover underlying biological mechanisms that drive and modulate disease. This approach enables to complement existing genomic analysis methods, extracting further insights from previously analysed data, or from smaller datasets that have been deemed unsuitable using existing approaches and by unpicking more complex genetics. The Company is currently applying Nomaly to therapeutic target discovery, as well as patient stratification for precision medicine, and has partnered with leading organisations including Genomics England and FinnGen.Content by OutSee
| 2 min read
Investment to leverage OutSee’s proprietary AI-based predictive genomics technology, Nomaly, to expand and progress in-house target development program
Page 1 of 1 - 1 Total Items
